0000899243-22-012858.txt : 20220330
0000899243-22-012858.hdr.sgml : 20220330
20220330203352
ACCESSION NUMBER: 0000899243-22-012858
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220330
FILED AS OF DATE: 20220330
DATE AS OF CHANGE: 20220330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aivado Manuel
CENTRAL INDEX KEY: 0001709603
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 22788677
MAIL ADDRESS:
STREET 1: C/O AILERON THERAPEUTICS, INC.
STREET 2: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-03-30
2022-03-24
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001709603
Aivado Manuel
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
1
1
0
0
See Remarks
Stock Option (right to buy)
0.48
2022-03-30
4
A
0
1133000
0.00
A
2032-03-29
Common Stock
1133000
1133000
D
This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.
President and Chief Executive Officer
/s/ Richard Wanstall, attorney in fact for Manuel Aivado
2022-03-30